245 related articles for article (PubMed ID: 18820946)
1. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
2. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
3. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Cheung IY; Cheung NK
Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.
Bao L; Dunham K; Lucas K
Cancer Immunol Immunother; 2011 Sep; 60(9):1299-307. PubMed ID: 21626030
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
6. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.
Söling A; Schurr P; Berthold F
Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332
[TBL] [Abstract][Full Text] [Related]
8. Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.
Xiao J; Chen HS; Fei R; Cong X; Wang LP; Wang Y; Jiang D; Wei L; Wang Y
J Gastroenterol; 2005 Jul; 40(7):716-21. PubMed ID: 16082588
[TBL] [Abstract][Full Text] [Related]
9. Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.
Corrias MV; Scaruffi P; Occhino M; De Bernardi B; Tonini GP; Pistoia V
Int J Cancer; 1996 Oct; 69(5):403-7. PubMed ID: 8900375
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2008 Apr; 14(7):1984-96. PubMed ID: 18381936
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
[TBL] [Abstract][Full Text] [Related]
12. Expression of MAGE A1-6 and the clinical characteristics of papillary thyroid carcinoma.
Lee HS; Kim SW; Hong JC; Jung SB; Jeon CH; Park JW; Park SY; Lee KD
Anticancer Res; 2013 Apr; 33(4):1731-5. PubMed ID: 23564824
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
Serrano A; Lethé B; Delroisse JM; Lurquin C; De Plaen E; Brasseur F; Rimoldi D; Boon T
Int J Cancer; 1999 Nov; 83(5):664-9. PubMed ID: 10521804
[TBL] [Abstract][Full Text] [Related]
14. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
[TBL] [Abstract][Full Text] [Related]
15. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
16. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
Mecklenburg I; Weckermann D; Zippelius A; Schoberth A; Petersen S; Prang N; Riethmüller G; Kufer P
J Immunol Methods; 2007 Jun; 323(2):180-93. PubMed ID: 17540401
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
Shin KC; Choi EY; Chung JH; Jeon C; Lee KH
Anticancer Res; 2012 Jan; 32(1):163-7. PubMed ID: 22213302
[TBL] [Abstract][Full Text] [Related]
18. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.
De Smet C; Loriot A; Boon T
Mol Cell Biol; 2004 Jun; 24(11):4781-90. PubMed ID: 15143172
[TBL] [Abstract][Full Text] [Related]
19. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of MAGE promoters during gastric cancer progression.
Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]